151 related articles for article (PubMed ID: 17725579)
21. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
[TBL] [Abstract][Full Text] [Related]
22. Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats.
Xu JT; Tu HY; Xin WJ; Liu XG; Zhang GH; Zhai CH
Exp Neurol; 2007 Aug; 206(2):269-79. PubMed ID: 17628541
[TBL] [Abstract][Full Text] [Related]
23. Painful purinergic receptors.
Donnelly-Roberts D; McGaraughty S; Shieh CC; Honore P; Jarvis MF
J Pharmacol Exp Ther; 2008 Feb; 324(2):409-15. PubMed ID: 18042830
[TBL] [Abstract][Full Text] [Related]
24. Upregulation and redistribution of ephrinB and EphB receptor in dorsal root ganglion and spinal dorsal horn neurons after peripheral nerve injury and dorsal rhizotomy.
Song XJ; Cao JL; Li HC; Zheng JH; Song XS; Xiong LZ
Eur J Pain; 2008 Nov; 12(8):1031-9. PubMed ID: 18321739
[TBL] [Abstract][Full Text] [Related]
25. P2X receptors: targets for novel analgesics?
Kennedy C
Neuroscientist; 2005 Aug; 11(4):345-56. PubMed ID: 16061521
[TBL] [Abstract][Full Text] [Related]
26. Noradrenaline stimulates ATP release from DRG neurons by targeting beta(3) adrenoceptors as a factor of neuropathic pain.
Kanno T; Yaguchi T; Nishizaki T
J Cell Physiol; 2010 Aug; 224(2):345-51. PubMed ID: 20432431
[TBL] [Abstract][Full Text] [Related]
27. Myocardial ischemic nociceptive signaling mediated by P2X3 receptor in rat stellate ganglion neurons.
Zhang C; Li G; Liang S; Xu C; Zhu G; Wang Y; Zhang A; Wan F
Brain Res Bull; 2008 Jan; 75(1):77-82. PubMed ID: 18158099
[TBL] [Abstract][Full Text] [Related]
28. [Neuropathic pain and ATP receptors in spinal microglia].
Tsuda M; Inoue K
Brain Nerve; 2007 Sep; 59(9):953-9. PubMed ID: 17886477
[TBL] [Abstract][Full Text] [Related]
29. Homomeric and heteromeric P2X3 receptors in peripheral sensory neurons.
Brederson JD; Jarvis MF
Curr Opin Investig Drugs; 2008 Jul; 9(7):716-25. PubMed ID: 18600577
[TBL] [Abstract][Full Text] [Related]
30. Effect of lappaconitine on neuropathic pain mediated by P2X3 receptor in rat dorsal root ganglion.
Ou S; Zhao YD; Xiao Z; Wen HZ; Cui J; Ruan HZ
Neurochem Int; 2011 Apr; 58(5):564-73. PubMed ID: 21272608
[TBL] [Abstract][Full Text] [Related]
31. Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain.
Hasegawa S; Kohro Y; Shiratori M; Ishii S; Shimizu T; Tsuda M; Inoue K
PLoS One; 2010 May; 5(5):e10467. PubMed ID: 20454616
[TBL] [Abstract][Full Text] [Related]
32. A-317491, a selective P2X3/P2X2/3 receptor antagonist, reverses inflammatory mechanical hyperalgesia through action at peripheral receptors in rats.
Wu G; Whiteside GT; Lee G; Nolan S; Niosi M; Pearson MS; Ilyin VI
Eur J Pharmacol; 2004 Nov; 504(1-2):45-53. PubMed ID: 15507220
[TBL] [Abstract][Full Text] [Related]
33. Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation.
Broom DC; Matson DJ; Bradshaw E; Buck ME; Meade R; Coombs S; Matchett M; Ford KK; Yu W; Yuan J; Sun SH; Ochoa R; Krause JE; Wustrow DJ; Cortright DN
J Pharmacol Exp Ther; 2008 Dec; 327(3):620-33. PubMed ID: 18772321
[TBL] [Abstract][Full Text] [Related]
34. ATP- and adenosine-mediated signaling in the central nervous system: chronic pain and microglia: involvement of the ATP receptor P2X4.
Inoue K; Tsuda M; Koizumi S
J Pharmacol Sci; 2004 Feb; 94(2):112-4. PubMed ID: 14978347
[TBL] [Abstract][Full Text] [Related]
35. VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X₂(/)₃ receptor of primary sensory neurons.
Lin J; Li G; Den X; Xu C; Liu S; Gao Y; Liu H; Zhang J; Li X; Liang S
Brain Res Bull; 2010 Oct; 83(5):284-91. PubMed ID: 20705122
[TBL] [Abstract][Full Text] [Related]
36. Antinociceptive properties of a non-nucleotide P2X3/P2X2/3 receptor antagonist.
McGaraughty S; Jarvis MF
Drug News Perspect; 2005 Oct; 18(8):501-7. PubMed ID: 16391720
[TBL] [Abstract][Full Text] [Related]
37. Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats.
Honore P; Kage K; Mikusa J; Watt AT; Johnston JF; Wyatt JR; Faltynek CR; Jarvis MF; Lynch K
Pain; 2002 Sep; 99(1-2):11-9. PubMed ID: 12237180
[TBL] [Abstract][Full Text] [Related]
38. P2X receptors and modulation of pain transmission: focus on effects of drugs and compounds used in traditional Chinese medicine.
Liang S; Xu C; Li G; Gao Y
Neurochem Int; 2010 Dec; 57(7):705-12. PubMed ID: 20863868
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain.
Ulmann L; Hatcher JP; Hughes JP; Chaumont S; Green PJ; Conquet F; Buell GN; Reeve AJ; Chessell IP; Rassendren F
J Neurosci; 2008 Oct; 28(44):11263-8. PubMed ID: 18971468
[TBL] [Abstract][Full Text] [Related]
40. P2X receptor ligands and pain.
Shieh CC; Jarvis MF; Lee CH; Perner RJ
Expert Opin Ther Pat; 2006 Aug; 16(8):1113-27. PubMed ID: 20144056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
